Find Grants

Search results

• Journalist Computer Programmers

  Gordon, R.

  John S. and James L. Knight Foundation

  10/1/11 → 6/30/30

  Project: Research project

• Interest for Journalist Computer Programmers

  Gordon, R.

  John S. and James L. Knight Foundation

  10/1/11 → 6/30/30

  Project: Research project

• Northwestern University Echo Core Lab (NUECL) for ALLEVIATE-HF-3 STUDY: The Safety and Efficacy of a Percutaneously Created Interatrial Shunt with the Alleviant System in Patients with Chronic Heart Failure and Preserved or Mid-Range Left Ventricular Ejec

  Narang, A.

  Alleviant Medical, Inc.

  2/24/22 → 2/23/31

  Project: Research project

• Aortic Valve Operative Outcomes in Marfan Patients

  Malaisrie, S. C.

  Baylor College of Medicine, National Marfan Foundation

  12/16/05 → 12/31/31

  Project: Research project

• Parkinson's Progression Markers Initiation (PPMI) 2.0

  Simuni, T.

  Michael J. Fox Foundation for Parkinson's Research

  8/10/20 → 7/31/33

  Project: Research project

• Chicagoland Regional Research in Sickle Cell Partnership (CRiSP)

  Thompson, A. A.

  American Society of Hematology

  2/28/20 → 2/27/50

  Project: Research project

• BMN 165-304: An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/day Dose) in Adults with Phenylketonuria

  Burton, B. K.

  BioMarin Pharmaceutical Inc.

  8/31/18 → 8/30/50

  Project: Research project

• LUM001 - ITCH (301) and IMAGINE (305) protocols, sponsor agreement in addition to funds supplied by the NIH ChiLDReN Grant (U01 DK-062456) and University of Michigan Subcontract (Lurie proposal 15-0334)

  Whitington, P. F.

  Lumena Pharmaceuticals, LLC

  8/1/14 → 8/30/50

  Project: Research project

• BioMarin 307-902: A Prospective ClinicalObservational Study of Phenylketonuria (PKU)

  Burton, B. K.

  BioMarin Pharmaceutical Inc.

  11/4/19 → 8/30/50

  Project: Research project

• Wool Clothing for Atopic Dermatitis: Assessment of potential therapeutic effects of Merino wool clothing in different geographical climates on atopic dermatitis in infants aged up to 5 years using clinical, quality of life and

  Paller, A.

  Northwestern University, Australian Wool Innovation Limited

  4/25/19 → 8/31/50

  Project: Research project

• AALL1931 (JAZZ) An Open-Label, Multicenter Study of RC-P in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to E. coli-derived Asparaginases

  Weinstein, J. L.

  Children’s Hospital of Philadelphia, Jazz Pharmaceuticals (EUSA Pharma USA) Inc.

  12/17/19 → 8/31/50

  Project: Research project

• PROTOSTAR CNTO1959PSO3011: A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in

  Paller, A.

  Northwestern University, Janssen Research & Development, LLC

  8/19/19 → 8/31/50

  Project: Research project

• (4045-301) A 48-Week, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients with Duchenne Muscular Dystrophy

  Kuntz, N. L.

  Sarepta Therapeutics, Inc.

  11/1/15 → 8/31/50

  Project: Research project

• Master Research Agreement

  Rigsby, C. K.

  Siemens Medical Solutions USA, Inc.

  5/20/09 → 8/31/50

  Project: Research project

• SRK-015-002: PHASE 2 ACTIVE TREATMENT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SRK-015 IN PATIENTS WITH LATER-ONSET SPINAL MUSCULAR ATROPHY (TOPAZ)

  Kuntz, N. L.

  Scholar Rock, Inc.

  6/6/19 → 8/31/50

  Project: Research project

• CP40559: A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF BALOXAVIR MARBOXIL IN OTHERWISE HEALTHYPEDIATRIC PATIENTS FROM BIRTH TO 1 YEAR WITH INFLUENZA-LIKE SYMPTOMS

  Muller, W. J.

  Genentech, Inc.

  3/11/19 → 8/31/50

  Project: Research project

• VX18-445-106-Part B: A Phase 3, Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX 445/TEZ/IVA Triple Combination Therapy in Cystic Fibrosis Subjects 6 Through 11 Years of Age

  McColley, S. A.

  Vertex Pharmaceuticals Incorporated

  8/9/19 → 8/31/50

  Project: Research project

• 4045-302. A Long-term, Open-label Extension Study for Patients with Duchenne Muscular Dystrophy Enrolled in Clinical Trials Evaluating Casimersen or Golodirsen

  Kuntz, N. L.

  Sarepta Therapeutics, Inc.

  8/3/18 → 8/31/50

  Project: Research project

• A Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children with Achondroplasia, Age 0 to < 60 Months (111-206)

  Charrow, J.

  BioMarin Pharmaceutical Inc.

  9/26/18 → 8/31/50

  Project: Research project

• 261203: A Phase 3, prospective, multi-center, open label study to investigate safety, immunogenicity, and hemostatic efficacy of PEGylated Factor VIII (BAX 855) in previously untreated patients (PUPs) < 6 years with severe hemo

  Thompson, A. A.

  Baxalta Innovations GmbH

  7/1/16 → 8/31/50

  Project: Research project

• Clinical Comparison of the BD FecalSwab Collection, Transport and Preservation System to the Cary-Blair Specimen or the Unpreserved Specimen on the BD MAX Enteric Assays

  Muller, W. J.

  Becton, Dickinson and Company

  2/25/20 → 8/31/50

  Project: Research project

• AveXis STRONG: A Phase I, Open-Label, Dose Comparison Study of AVXS-101 for Sitting but Non-ambulatory Patients with Spinal Muscular Atrophy

  Kuntz, N. L.

  AveXis, Inc.

  10/4/17 → 8/31/50

  Project: Research project

• An open label, expanded access protocol intended to provide treatment with MP-104 (deflazacort) to U.S. children, adolescents, and/or adults with Duchenne muscular dystrophy

  Kuntz, N. L.

  Marathon Pharmaceuticals, LLC

  4/26/16 → 8/31/50

  Project: Research project

• Sarepta 5051-102: An Open-Label Extension Study for Patients with Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051

  Kuntz, N. L.

  Sarepta Therapeutics, Inc.

  3/26/19 → 8/31/50

  Project: Research project

• 4045-101: A Randomized, Double Blind, Placebo Controlled, Dose Titration, Safety,Tolerability, and Pharmacokinetics Study Followed by an Open Label Safety and EfficacyEvaluation of SRP 4045 in Advanced Stage Patients with Duchenne Muscular Dyst

  Kuntz, N. L.

  Sarepta Therapeutics, Inc.

  11/1/15 → 8/31/50

  Project: Research project